1. Home >
  2. M&A >
  3. Venture >
  4. Netherlands >
  5. Eight Roads Invests In Castor

Investment Summary

Eight Roads Invests In Castor

On July 14, 2021, private equity firm Eight Roads invested in internet software and services company Castor

Investment Highlights
  • This is Eight Roads’ 56th transaction in the Internet Software and Services sector.
  • This is Eight Roads’ 2nd transaction in the Netherlands.

Investment Summary
Date 2021-07-14
Target Castor
Sector Internet Software and Services
Investor(s) Eight Roads
Deal Type Venture

Target

Castor

Amsterdam, Netherlands
Castor is a clinical trial software company that provides a self-service version enabling researchers to design studies and integrate in-person and remote patient data from any source in real-time. Patients interested in joining trials can enroll and share their data via a mobile app. Castor was founded in 2011 and is based in Amsterdam, Netherlands.

Search 215,130 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Eight Roads

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1969
PE ASSETS 11.0B USD
Size Mega
Type Sector Focused
DESCRIPTION

Eight Roads is a private investment firm focused on a variety of investment opportunities across the US, Europe, and Asia. The Firm is divided into several investment strategies including venture, principal investing, and real estate. Within the principal investments group, Eight Roads backs established growth businesses with long-term capital. Eight Roads does not have any sector preferences, but has experience in fintech, business services, and healthcare. Eight Roads is based in London.

DEAL STATS #
Overall 255 of 293
Sector: Internet Software and Services M&A 56 of 60
Type: Venture M&A Deals 231 of 266
Country: Netherlands M&A 2 of 2
Year: 2021 M&A 15 of 29
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-06-17 Verve Therapeutics

Cambridge, Massachusetts, United States

Verve Therapeutics is a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. Verve Therapeutics was founded in 2018 and is based in Cambridge, Massachusetts.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-07-16 Blueglass Yogurt

Beijing, China

Blueglass Yogurt is an operator of a yogurt chain brand in China that serves fresh yogurt to domestic consumers. Blueglass Yogurt was founded in 2012 and is based in Beijing, China.

Buy -
Mergr

Solution for

Product

Company

Legal